CoChat

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b

Suzuki, M, Yamada, T, Kihara-Negishi, F, Sakurai, T, Hara, E, Tenen, D G, Hozumi, N, Oikawa, T · 2006 · Oncogene

Abstract

The Ets transcription factor PU.1 is a hematopoietic master regulator essential for the development of myeloid and B-cell lineages. As we previously reported, PU.1 sometimes represses transcription on forming a complex with mSin3A-histone deacetyl transferase-MeCP2. Here, we show an interaction between PU.1 and DNA methyltransferases, DNA methyltransferase (Dnmt)3a and Dnmt3b (Dnmt3s). Glutathione-S-transferase pulldown assay revealed that PU.1 directly interacted with the ATRX domain of Dnmt3s through the ETS domain. Dnmt3s repressed the transcriptional activity of PU.1 on a reporter construct with trimerized PU.1-binding sites. The repression was recovered by addition of 5-aza-deoxycitidine, a DNA methyltransferase inhibitor, but not trichostatin A, a histone deacetylase inhibitor. Bisulfite sequence analysis revealed that several CpG sites in the promoter region neighboring the PU.1-binding sites were methylated when Dnmt3s were coexpressed with PU.1. We also showed that the CpG sites in the p16(INK4A) promoter were methylated by overexpression of PU.1 in NIH3T3 cells, accompanied by a downregulation of p16(INK4A) gene expression. These results suggest that PU.1 may downregulate its target genes through an epigenetic modification such as DNA methylation.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1209272

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Research works printed but not linked: 1

  1. Zhang DE, Hetherington CJ, Chen HM, Tenen DG . (1994). Mol Cell Biol 14: 373–381. · doi:10.1128/mcb.14.1.373 · Paper page

Cited by

See all 133

Metadata

Authors
Suzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., Hara, E., Tenen, D. G., Hozumi, N., & Oikawa, T.
Affiliations
  • Sasaki Institute (JP)
  • Tokushima University (JP)
  • Harvard University (US)
  • Tokyo University of Science (JP)
Corresponding author
Oikawa, T
Venue
Oncogene
Published
2005-12-05
Volume
25
Issue
17
Pages
2477-2488
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W1984410404
Cited by
132
References
43
Citations by year
2026: 3 · 2025: 2 · 2024: 4 · 2023: 1 · 2022: 10 · 2021: 6 · 2020: 9 · 2019: 8 · 2018: 4 · 2017: 2 · 2016: 11 · 2015: 5 · 2014: 7 · 2013: 10 · 2012: 4
FWCI
2.37
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
Keywords
PU.1, DNMT3A, DNMT3B, DNA methylation, transcriptional repression, ETS transcription factors, CpG methylation, p16INK4a, epigenetic regulation, hematopoietic transcription factors, decitabine
MeSH terms
Decitabine, DNA Methyltransferase 3A, DNA Methyltransferase 3B, Proto-Oncogene Protein Spi-1, Animals, Azacitidine, DNA (Cytosine-5-)-Methyltransferases, Histone Deacetylases, Hydroxamic Acids, Promoter Regions, Genetic, Proto-Oncogene Proteins, Transcription, Genetic, Trans-Activators, DNA Methylation, Cyclin-Dependent Kinase Inhibitor p16, NIH 3T3 Cells, Chromatin Immunoprecipitation, Immunoprecipitation, Mice, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.